Mattias Münnich

Mattias Münnich

Director/Board Member at
Magamu AB
47 year
Health Technology
Consumer Services
Commercial Services

Profile

Mattias Münnich founded Stayble Therapeutics AB in 2015, where he worked as Chief Operating Officer from 2022 to 2023.
Mr. Münnich also founded PharmaSurgics In Sweden AB, where he worked as Manager-Business Development.
Mr. Münnich also currently works at Magamu AB, as Director from 2011, Alpha Theraphy Solutions AB, as Director from 2019, Atley Solutions AB, as Director, and Chalmers Ventures AB, as Seed Investment Manager from 2024.
Mr. Münnich also formerly worked at AcuCort AB, as Chief Executive Officer, Mevia AB, as Director, and Ziccum AB, as Independent Director from 2018 to 2022.
Mr. Münnich received his undergraduate degree and graduate degree from Chalmers School of Entrepreneurship.

Mattias Münnich active positions

CompaniesPositionStart
Director/Board Member 01/01/2011
Alpha Theraphy Solutions AB
Director/Board Member 01/01/2019
Director/Board Member -
Private Equity Investor 01/02/2024

Former positions of Mattias Münnich

CompaniesPositionEnd
STAYBLE THERAPEUTICS AB Founder 01/12/2023
ZICCUM AB Director/Board Member 01/05/2022
ACUCORT AB Chief Executive Officer -
Director/Board Member -
Founder -
See the detail of Mattias Münnich's experience

Training of Mattias Münnich

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

5

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Commercial Services

Alpha Theraphy Solutions AB

Commercial Services

  1. Stock Market
  2. Insiders
  3. Mattias Münnich
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!